Claire E. Ashton‐James

2.9k total citations · 1 hit paper
69 papers, 1.6k citations indexed

About

Claire E. Ashton‐James is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Claire E. Ashton‐James has authored 69 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 18 papers in Public Health, Environmental and Occupational Health and 17 papers in General Health Professions. Recurrent topics in Claire E. Ashton‐James's work include Musculoskeletal pain and rehabilitation (28 papers), Opioid Use Disorder Treatment (14 papers) and Pain Management and Opioid Use (9 papers). Claire E. Ashton‐James is often cited by papers focused on Musculoskeletal pain and rehabilitation (28 papers), Opioid Use Disorder Treatment (14 papers) and Pain Management and Opioid Use (9 papers). Claire E. Ashton‐James collaborates with scholars based in Australia, United States and Netherlands. Claire E. Ashton‐James's co-authors include Neal M. Ashkanasy, Jerald Greenberg, Elizabeth W. Dunn, Tanya L. Chartrand, Marc A. Brackett, Jessica L. Tracy, Peter Salovey, Kostadin Kushlev, Johan C. Karremans and Rick B. van Baaren and has published in prestigious journals such as Journal of Personality and Social Psychology, PLoS ONE and Psychological Science.

In The Last Decade

Claire E. Ashton‐James

64 papers receiving 1.5k citations

Hit Papers

Psychological interventions for chronic, non-specific low... 2022 2026 2023 2024 2022 25 50 75 100

Peers

Claire E. Ashton‐James
Kurt F. Geisinger United States
Fong Chan United States
Matthew Hunsinger United States
Ladislav Valach Switzerland
Brian M. Quigley United States
Mark H. Anshel United States
Kurt F. Geisinger United States
Claire E. Ashton‐James
Citations per year, relative to Claire E. Ashton‐James Claire E. Ashton‐James (= 1×) peers Kurt F. Geisinger

Countries citing papers authored by Claire E. Ashton‐James

Since Specialization
Citations

This map shows the geographic impact of Claire E. Ashton‐James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire E. Ashton‐James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire E. Ashton‐James more than expected).

Fields of papers citing papers by Claire E. Ashton‐James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire E. Ashton‐James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire E. Ashton‐James. The network helps show where Claire E. Ashton‐James may publish in the future.

Co-authorship network of co-authors of Claire E. Ashton‐James

This figure shows the co-authorship network connecting the top 25 collaborators of Claire E. Ashton‐James. A scholar is included among the top collaborators of Claire E. Ashton‐James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire E. Ashton‐James. Claire E. Ashton‐James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gholamrezaei, Ali, et al.. (2025). Pregabalin dependence, withdrawal, suicidality and psychosis reports: A disproportionality analysis of the Australian adverse events database. British Journal of Clinical Pharmacology. 92(2). 545–555. 1 indexed citations
2.
Ashton‐James, Claire E., et al.. (2025). A scoping review of factors associated with Australian university student wellbeing. International Journal of Wellbeing. 15(1). 1–45. 2 indexed citations
4.
Gholamrezaei, Ali, et al.. (2024). Impact of healthcare interventions on distress following acute musculoskeletal/orthopaedic injury: a scoping review of systematic reviews. BMJ Open. 14(7). e085778–e085778. 2 indexed citations
5.
Kapos, Flavia P., Kenneth D. Craig, Steven R. Anderson, et al.. (2024). Social Determinants and Consequences of Pain: Toward Multilevel, Intersectional, and Life Course Perspectives. Journal of Pain. 25(10). 104608–104608. 26 indexed citations
6.
Nielsen, Suzanne, et al.. (2024). Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review. International Journal of Drug Policy. 133. 104605–104605. 4 indexed citations
7.
Gholamrezaei, Ali, Manuela L. Ferreira, Beth D. Darnall, et al.. (2024). A digital health intervention to support patients with chronic pain during prescription opioid tapering: a pilot randomised controlled trial. PAIN Reports. 9(2). e1128–e1128. 3 indexed citations
8.
Rebbeck, Trudy, et al.. (2024). Claimant and clinician perspectives on sources of claimant distress in interactions with Australian compensation schemes: a qualitative study. Disability and Rehabilitation. 47(13). 3323–3333. 1 indexed citations
9.
Rebbeck, Trudy, et al.. (2024). Clinician Experiences of and Responses to the Challenges of Working with Patients in the Australian Compensation Setting. Journal of Occupational Rehabilitation. 35(3). 641–653.
11.
Nielsen, Suzanne, et al.. (2023). Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review protocol. BMJ Open. 13(9). e073770–e073770. 2 indexed citations
12.
Ashton‐James, Claire E., et al.. (2023). “We were all looking for the magic pill”: A qualitative study of patient experiences using gabapentinoids for chronic pain. International Journal of Drug Policy. 119. 104112–104112. 4 indexed citations
14.
Gholamrezaei, Ali, et al.. (2022). A Digital Video and Text Messaging Intervention to Support People With Chronic Pain During Opioid Tapering: Content Development Using Co-design. JMIR Formative Research. 6(11). e40507–e40507. 6 indexed citations
16.
Stanaway, Fiona, et al.. (2022). Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis. BMJ. 377. e066375–e066375. 24 indexed citations
17.
Wilson, Dianne, Shylie Mackintosh, Michael K. Nicholas, et al.. (2022). Are group identity and sense of belonging relevant for group pain management programmes? An exploratory pilot study. British Journal of Pain. 16(5). 528–537. 2 indexed citations
18.
Mardian, Aram S., Luzmercy Perez, Ming‐Chih Kao, et al.. (2021). Engagement in Prescription Opioid Tapering Research: the EMPOWER Study and a Coproduction Model of Success. Journal of General Internal Medicine. 37(S1). 113–117. 7 indexed citations
19.
Glare, Paul, et al.. (2021). mHealth Interventions to Support Prescription Opioid Tapering in Patients With Chronic Pain: Qualitative Study of Patients’ Perspectives. JMIR Formative Research. 5(5). e25969–e25969. 14 indexed citations
20.
Glare, Paul, et al.. (2021). A qualitative trajectory analysis of patients' experiences tapering opioids for chronic pain. Pain. 163(2). e246–e260. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026